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Background/introduction
The Kona Medical Surround Sound™ System is a fully
non-invasive system for renal denervation which employs
ultrasound based imaging for targeting and tracking as
well as a phased array therapeutic ultrasound transducer.
To date, 69 patients have been treated under three differ-
ent protocols (WAVE I, WAVE II, and WAVE III).
Follow up ranges from 3 months to over 2 years. A
subset of 18 patients (WAVE II) was chosen for detailed
analysis using numerical simulation. Aims: To evaluate
safety, feasibility, and a specific dose strategy using a
computational model in a Virtual Acoustic Patient (VAP)
model and validate these simulations with human data.
Methods
A 3D human body acoustic and thermal simulation mod-
els has been developed. The model utilizes the cross sec-
tional imaging from MRI or CT of the treated patients
and translates these images into 3D acoustic models.
Subsequently, the key parameters and variables that
influence the efficacy and safety of the high intensity
therapeutic ultrasound (HITU) treatment were incorpo-
rated into the model. Specific anatomic regions which
relate to safety and efficacy were highlighted in the
model.
Results and conclusions
The simulations in the virtual acoustic patient models
demonstrated the following:
1. The therapeutic dose creates a thermal lesion
around the renal artery.
2. There are no significant pre-focal or post-focal
regions of unwanted thermal or mechanical tissue damage
in vital organs including the kidneys, spine, and bowel.
3. The maximum peak temperature used in the clini-
cal trials is below the thermally-induced cavitation using
the most extreme clinical conditions and absorption
coefficients.
4. The contribution of non-linear content in the
acoustic waveform is minimal and is highly unlikely to
result in any significant unintended mechanical biologi-
cal effects such as cavitation.
5. There is potential for unwanted heating starting from
the fat/muscle interface and inside fat layer using the
extremes of absorption coefficients and patients depths.
Clinical data in 58 patients who have reached 6 mos
follow-up show an average blood pressure drop of 24/10
from baseline and an acceptable safety profile.
Conclusions: Computational ultrasound modeling and
simulation developed using the virtual acoustic patient mod-
els provides a powerful tool for evaluating and validating the
mechanical and thermal effects of treatment protocol used
in the clinical for renal denervation. Clinical data correlates
well with the simulation and provides validating evidence
that the simulation can be predictive of clinical results.
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